Cargando…
Circulating microRNA-103a-3p could be a diagnostic and prognostic biomarker for breast cancer
Breast cancer (BC) is the most frequent cancer for women worldwide. Recently, a spectrum of cell-free circulating microRNAs (miR) has been recognized as promising biomarkers for BC diagnosis and prognosis, among which miR-103a-3p has been reported in several types of human cancer. However, the role...
Autores principales: | Liu, Hui, Bian, Qing-Zhao, Zhang, Wei, Cui, Hai-Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669650/ https://www.ncbi.nlm.nih.gov/pubmed/34966454 http://dx.doi.org/10.3892/ol.2021.13156 |
Ejemplares similares
-
Circulating microRNAs in breast cancer: novel diagnostic and prognostic biomarkers
por: Hamam, Rimi, et al.
Publicado: (2017) -
Circulating Biomarkers for Cancer Detection: Could Salivary microRNAs Be an Opportunity for Ovarian Cancer Diagnostics?
por: Robotti, Marzia, et al.
Publicado: (2023) -
Circulating microRNAs as Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma
por: Jin, Yu, et al.
Publicado: (2019) -
Circulating microRNAs as the Potential Diagnostic and Prognostic Biomarkers for Nasopharyngeal Carcinoma
por: Le, Thuy Ai Huyen, et al.
Publicado: (2022) -
A circulating microRNA signature as noninvasive diagnostic and prognostic biomarkers for nonalcoholic steatohepatitis
por: Liu, Jie, et al.
Publicado: (2018)